GT
ANAC

Glenmede Trust’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

Glenmede Trust’s Portfolio ANAC Stock Details ANAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-36
Closed -$1K – 2930
2016
Q1 		$1K Buy
+36
New +$2.66K ﹤0.01% 2591

Other funds holding ANAC

KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
CIM
CIM Investment Management Pittsburgh, Pennsylvania $375M AUM 32.03% 1-Year Est. Return

Glenmede Trust's ANAC Position: Q2 2016 in Review

Glenmede Trust sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q2 2016, closing a stake of 36 shares — an estimated $1K sold.

Glenmede Trust first reported a position in ANAC in Q1 2016 and held it in 1 quarter. The position peaked at $1K in Q1 2016. 2 funds tracked by Wall St. Rank hold ANAC as of Q2 2016.

  • Glenmede Trust reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q2 2016 after selling out during the quarter.
  • Glenmede Trust sold 36 ANACOR PHARMACEUTICALS INC COM shares in Q2 2016, an estimated $1K.
  • Glenmede Trust first reported a position in ANACOR PHARMACEUTICALS INC COM in Q1 2016 and held it in 1 quarter.
  • Glenmede Trust's ANACOR PHARMACEUTICALS INC COM position peaked at $1K in Q1 2016.
  • 2 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q2 2016.

Based on Glenmede Trust's 13F filing for Q2 2016, filed 5 Aug 2016.